Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Clinical trial NCT01944527 · UNKNOWN

Trial details

NCT number: NCT01944527
Sponsor: ANRS, Emerging Infectious Diseases
Status: UNKNOWN
Study type: OBSERVATIONAL

HCV Recurrence Liver Transplantation Direct-acting Antiviral Agents

Start date: 2013-10-01
Primary completion: 2015-12-01
Enrollment: 699

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.